Physician

Maria Stephanie R. Jardeleza, MD

According to 2025 Medicare claims, Maria Jardeleza, MD (NPI: 1518125509) practices ophthalmology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is RETINA ASSOCIATES, PLLC (NPI: 1760408397; TIN: 562043271) and primary practice location at 27834-3796.

Jardeleza's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 516 traditional Medicare patients, billed 9,512 HCPCS/CPT codes, and received $927,663 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 351 prescription claims across 146 beneficiaries totaling $10,778 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 15 records totaling $2,437. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $189,005 to $927,663. In contrast, Part D prescription costs have fallen sharply in recent years, from $11,310 to $10,778. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$737K$1.5M2015 Medicare payment: $189,005 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $127,202 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $175,930 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $298,212 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $383,514 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $308,873 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $671,428 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,473,232 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,409,924 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $927,663 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151861,380$189,005
20161491,062$127,202
20171341,130$175,930
20182031,786$298,212
20192872,316$383,514
20202301,832$308,873
20214002,429$671,428
20224385,060$1,473,232
202341411,334$1,409,924
20245169,512$927,663

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$24K$48K2015 Drug cost: $11,310 (USD; Tot_Drug_Cst)2016 Drug cost: $11,905 (USD; Tot_Drug_Cst)2017 Drug cost: $30,009 (USD; Tot_Drug_Cst)2018 Drug cost: $38,339 (USD; Tot_Drug_Cst)2019 Drug cost: $47,625 (USD; Tot_Drug_Cst)2020 Drug cost: $48,154 (USD; Tot_Drug_Cst)2021 Drug cost: $30,850 (USD; Tot_Drug_Cst)2022 Drug cost: $24,174 (USD; Tot_Drug_Cst)2023 Drug cost: $15,104 (USD; Tot_Drug_Cst)2024 Drug cost: $10,778 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201541130$11,310
201643104$11,905
2017117324$30,009
2018341789$38,339
2019398831$47,625
2020171367$48,154
2021104310$30,850
2022120442$24,174
2023106307$15,104
2024146351$10,778

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye173516$92
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more149150$76
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more295433$65
92134Imaging of retina274578$30
92250Photography of the retina428524$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate823,737$4,449
Ketorolac TromethamineKetorolac Tromethamine481,789$1,451
Dorzolamide HclDorzolamide Hcl362,037$604
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha44539$489
Timolol MaleateTimolol Maleate251,917$221

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.15$2,437Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Maria Stephanie R. Jardeleza, MD?

Tedicare shows public-source Medicare data for Maria Stephanie R. Jardeleza, MD (NPI 1518125509), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Maria Stephanie R. Jardeleza, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Maria Stephanie R. Jardeleza, MD?

Maria Stephanie R. Jardeleza, MD is linked to RETINA ASSOCIATES, PLLC (billing NPI 1760408397) in the available physician profile data.

Does Maria Stephanie R. Jardeleza, MD have Open Payments data?

Maria Stephanie R. Jardeleza, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.